Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Weild & Co. is an issuer-focused investment bank with deep expertise in the life sciences sector. The firm provides M&A advisory, capital formation, and strategic consulting to companies in medical devices, diagnostics, pharmaceuticals (including branded/generic drugs and biologics), biotechnology, nutraceuticals, health technology (telemedicine/AI), and related fields[1][2][4]. It does not develop its own therapeutic products or maintain a clinical pipeline but has supported numerous transactions for clients in these industries[1].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Weild & Co..